Isopeg

Polyethylene glycol 3350 with electrolytes, the active ingredient in Isopeg, is an osmotic laxative presented as an oral solution for oral administration. It is indicated for the treatment of functional constipation and for bowel cleansing prior to colonoscopic examination in adult patients.

GNH USA supplies Isopeg as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution. Isopeg is manufactured under EU GMP guidelines and is available for export to multiple regions.

Isopeg, an osmotic laxative, is employed to manage disorders of bowel motility and to prepare the colon for diagnostic procedures.

- Constipation: softens stool and promotes regular bowel movements in adults with functional constipation. - Bowel preparation for colonoscopy: clears the intestinal lumen to enable clear visualization during colonoscopic examination. - Prevention of fecal impaction: maintains stool softness to reduce risk of hard stool accumulation in at‑risk patients. - Pre‑operative bowel cleansing: used before certain abdominal surgeries to reduce fecal load.

Common Side Effects: - Abdominal bloating: sensation of fullness or swelling in the abdomen. - Nausea: mild feeling of queasiness that may occur after ingestion. - Flatulence: increased intestinal gas leading to discomfort. - Diarrhoea: loose stools occurring if the dose exceeds individual tolerance.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body water requiring medical attention. - Electrolyte disturbances: significant shifts in sodium, potassium or chloride levels. - Allergic reaction: rash, itching, swelling or difficulty breathing indicating hypersensitivity.

Isopeg should be used with clinical judgment and appropriate monitoring. - Renal function assessment: evaluate kidney status before initiating therapy. - Electrolyte monitoring: check serum electrolytes, especially in patients with cardiac or renal disease. - Caution in heart failure: avoid excessive fluid shifts that may exacerbate condition. - Avoid in bowel obstruction: contraindicated when mechanical blockage is present. - Dose adjustment in elderly: consider lower initial dose due to altered tolerance. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Isopeg may interact with other medications that affect fluid or electrolyte balance.

Major Interactions (Avoid): - Concomitant osmotic laxatives: risk of excessive fluid loss. - Loop diuretics: may precipitate severe electrolyte imbalance. - Sodium‑containing IV fluids: increase risk of hypernatremia.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may reduce laxative efficacy. - Opioid analgesics: can counteract the bowel‑stimulating effect. - Mineral supplements (e.g., potassium chloride): may alter electrolyte homeostasis.